Fred Aslan, Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 61,696 shares at $6.84 ($422K) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Open-market sale of $422k ARTV by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARTV | SELL | 2026-09-04 | $690K | — | Filing → |
| ARTV | SELL | 2026-05-19 | $244K | — | Filing → |
| ARTV | SELL | 2025-12-15 | $19K | — | Filing → |